PH insider: 4,444 Stock Appreciation Rights granted to VP & Chief Digital Officer
Rhea-AI Filing Summary
Parker-Hannifin insider grant: The Form 4 shows that Dinu J. Parel, VP & Chief Digital & Info Officer and a company officer, was allocated 4,444 Stock Appreciation Rights (SARs) on 08/20/2025. The SARs have a grant reference price of $742.97, vest in three equal annual installments beginning 08/20/2026, and expire on 08/19/2035. Each SAR is tied to one share of Parker-Hannifin common stock, representing 4,444 underlying shares reported as directly beneficially owned following the transaction. The Form 4 is signed by an attorney-in-fact on behalf of the reporting person.
Positive
- 4,444 Stock Appreciation Rights granted to an executive officer, clearly disclosed
- Vesting schedule provided: vests in three equal annual installments beginning 08/20/2026
- Long-term horizon: expiration date 08/19/2035 gives extended performance alignment
Negative
- None.
Insights
TL;DR: Officer received SAR award of 4,444 units vesting annually from 08/20/2026, aligning long-term compensation with share performance.
The filing documents a standard equity-based compensation grant: 4,444 stock appreciation rights with a reference price of $742.97, exercisable in part beginning 08/20/2026 and expiring 08/19/2035. The award vests in three equal annual installments, per the explanatory note. For investors and governance reviewers, this is a routine disclosure of insider compensation rather than a market-moving transaction; it increases potential future dilution if exercised but provides no immediate cash proceeds or share issuance as of the reporting date.
TL;DR: The grant is a typical long-term incentive that creates future alignment between executive and shareholder interests.
The Form 4 shows direct beneficial ownership of 4,444 SARs by an executive officer. Vesting over three years and a long expiration horizon (10 years) are common governance features designed to retain executives and tie pay to performance. The disclosure is complete regarding grant size, price, vesting commencement, and expiration date, enabling assessment of potential dilution and pay structure without further inference.